Literature DB >> 19968818

Anticipating drug resistance in the MAP kinase pathway.

Ronen Marmorstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19968818      PMCID: PMC4026329          DOI: 10.1111/j.1755-148X.2009.00657.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  5 in total

Review 1.  Targeting cancer with small molecule kinase inhibitors.

Authors:  Jianming Zhang; Priscilla L Yang; Nathanael S Gray
Journal:  Nat Rev Cancer       Date:  2009-01       Impact factor: 60.716

Review 2.  Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Ellis W T Wong; Fumin Chang; Brian Lehmann; David M Terrian; Michele Milella; Agostino Tafuri; Franca Stivala; Massimo Libra; Jorg Basecke; Camilla Evangelisti; Alberto M Martelli; Richard A Franklin
Journal:  Biochim Biophys Acta       Date:  2006-10-07

Review 3.  Imatinib resistance in CML.

Authors:  Gisella Volpe; Cristina Panuzzo; Stefano Ulisciani; Daniela Cilloni
Journal:  Cancer Lett       Date:  2008-07-23       Impact factor: 8.679

4.  MEK1 mutations confer resistance to MEK and B-RAF inhibition.

Authors:  Caroline M Emery; Krishna G Vijayendran; Marie C Zipser; Allison M Sawyer; Lili Niu; Jessica J Kim; Charles Hatton; Rajiv Chopra; Patrick A Oberholzer; Maria B Karpova; Laura E MacConaill; Jianming Zhang; Nathanael S Gray; William R Sellers; Reinhard Dummer; Levi A Garraway
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-13       Impact factor: 11.205

Review 5.  Integrating BRAF/MEK inhibitors into combination therapy for melanoma.

Authors:  K S M Smalley; K T Flaherty
Journal:  Br J Cancer       Date:  2009-01-20       Impact factor: 7.640

  5 in total
  1 in total

Review 1.  Mechanisms of drug resistance in kinases.

Authors:  Rina Barouch-Bentov; Karsten Sauer
Journal:  Expert Opin Investig Drugs       Date:  2011-02       Impact factor: 6.206

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.